Biliary Sepsis Due to Recurrent Acute Calculus Cholecystitis (ACC) in a High Surgical-Risk Elderly Patient: An Unexpected Complication.
Giacomo SermonesiAlessia RampiniGirolamo ConvertiniRaffaele BovaNicola ZaniniRiccardo BertelliCarlo VallicelliFrancesco FaviGiacomo StacchiniEnrico FaccaniNicola FabbriFausto CatenaPublished in: Pathogens (Basel, Switzerland) (2022)
Acute calculus cholecystitis (ACC) is increasing in frequency within an ageing population, in which biliary tract infection, including cholecystitis and cholangitis, is the second most common cause of sepsis, with higher morbidity and mortality rates. Patient's critical conditions, such as septic shock or anaesthesiology contraindication, may be reasons to avoid laparoscopic cholecystectomy-the first-line treatment of ACC-preferring gallbladder drainage. It can aid in patient's stabilization with also the benefit of identifying the causative organism to establish a targeted antibiotic therapy, especially in patients at high risk for antimicrobial resistance such as healthcare-associated infection. Nevertheless, a recent randomized clinical trial showed that laparoscopic cholecystectomy can reduce the rate of major complications compared with percutaneous catheter drainage in critically ill patients too. On the other hand, among the possibilities to control biliary sepsis in non-operative management of ACC, according to recent meta-analysis, endoscopic gallbladder drainage showed better clinical success rate, and it is gaining popularity because of the potential advantage of allowing gallstones clearance to reduce recurrences of ACC. However, complications that may arise, although rare, can worsen an already weak clinical condition, as happened to the high surgical-risk elderly patient taken into account in our case report.
Keyphrases
- case report
- septic shock
- ultrasound guided
- healthcare
- antimicrobial resistance
- systematic review
- intensive care unit
- liver failure
- acute kidney injury
- end stage renal disease
- chronic kidney disease
- ejection fraction
- stem cells
- clinical trial
- randomized controlled trial
- cancer therapy
- mesenchymal stem cells
- bone marrow
- aortic dissection
- peritoneal dialysis
- hepatitis b virus
- patient reported outcomes
- meta analyses
- smoking cessation
- radiofrequency ablation